TGTX   $25.27  0.06% Market Closed After Close 25.7 1.70%

TG Therapeutics Inc
Total Cash 217.25M
totalCashPerShare 1.514
EBITDA 102.00M
Total Debt 112.92M
quickRatio 2.769
currentRatio 3.581
Total Revenue 346.72M
debtToEquity 63.592
Revenue/Share 2.404
ROA 0.20465
ROE 0.87776
grossProfits
freeCashflow 23.81M
operatingCashflow 67.82M
earningsGrowth
revenueGrowth 3.57
grossMargins 0.92759
ebitdaMargins 0.29419002
operatingMargins 0.12
profitMargins 0.27597
enterpriseValue 3.30B
forwardPE 31.64
floatShares 133.47M
sharesOutstanding 154.82M
sharesShort 29.51M
sharesShortPriorMonth 31.17M
dateShortInterest
sharesPercentSharesOut 0.19%
heldPercentInsiders 0.10%
heldPercentInstitutions 0.61%
Short Ratio help_outline 8.26%
shortPercentOfFloat 0.21%
impliedSharesOutstanding
bookValue 1.238
Price To Book help_outline 19.17
earningsQuarterlyGrowth
netIncomeToCommon 95.69M
trailingEps 0.68%
forwardEps 0.75%
enterpriseToEbitda 32.35
lastDividendValue
lastDividendDate
currentQuarterEstimate 0.02 3Q 2024
institutionsCount 332
lastUpdated Sept. 16, 2024, noon